In a significant development in the healthcare sector, Iswarya Health Private Limited has successfully secured a substantial primary investment of ₹355 crore from OrbiMed Asia VI Mauritius Limited, a renowned investment arm of OrbiMed. The transaction marks a pivotal step in Iswarya Health’s growth trajectory, aimed at broadening its reach and enhancing its service offerings.
Trilegal’s Role in the Transaction
Trilegal, a prominent legal advisory firm, played a crucial role in advising Iswarya Health and its promoters—Dr. Arun Muthuvel, Dr. S. Chandralekha, and Dr. K. Veluswamy—during this transaction. The legal team was spearheaded by Partner Rahul Chugh, with significant contributions from Senior Associate Kriti Chatrath and Associate Samridhi Poddar.
Iswarya Health’s Expansion Plans
Headquartered in Chennai, Iswarya Health has established itself as a leading provider of fertility services. Over the years, it has expanded its operations to include a multispecialty hospital equipped with more than 400 beds and cutting-edge infrastructure. The recent infusion of funds from OrbiMed will enable Iswarya Health to set up new centers in both existing and underserved markets, thereby broadening access to quality fertility care across India.
Strategic Investments in Infrastructure and Talent
The investment will also be channeled towards enhancing Iswarya Health’s clinical infrastructure, boosting its digital capabilities, and strengthening its embryology talent pool. These strategic initiatives are designed to support the healthcare provider’s next phase of growth, ensuring that high-quality fertility services are accessible to a larger demographic.
This transaction underscores the growing interest in the Indian healthcare sector, particularly in specialized fields such as fertility services. The collaboration with OrbiMed is expected to provide Iswarya Health with the resources and strategic guidance necessary for scaling its operations and achieving its long-term objectives.
More Read
For individuals or firms interested in having their deals, columns, or press releases published on Bar & Bench, a submission form is available here.
